4732.TWO NatureWise Biotech & Medicals Corporation

Healthcare Biotechnology Taiwan OTC Exchange
14.80 TWD
Close of Nov 6, 2026
14.70 24.60
Market cap
TWD 717M
P/E
-
P/B
1.35x
ROE
-14.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 4732.TWO undervalued?

Graham number

The Graham number of NatureWise Biotech & Medicals Corporation cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NatureWise Biotech & Medicals Corporation fundamental analysis

No fundamental analysis for NatureWise Biotech & Medicals Corporation yet.

NatureWise Biotech & Medicals Corporation stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NatureWise Biotech & Medicals Corporation

NatureWise Biotech & Medicals Corporation engages in the research and development of Western medicine, Chinese medicine, and biotechnology in Taiwan. It also sells food and beverages. It offers LipoCol Forte, a capsule for hypercholesterolemia and hypertriglyceridemia; and green propolis and red yeast rice products. The company was founded in 1990 and is headquartered in Taipei, Taiwan.

Full company profile